Wells Fargo Downgrades Health Catalyst to Equal-Weight, Lowers Price Target to $1
Benzinga Newsdesk 7 months ago
NewsDowngradesPrice TargetAnalyst Ratings
Wells Fargo analyst Stan Berenshteyn downgrades Health Catalyst (NASDAQ:HCAT) from Overweight to Equal-Weight and lowers the price target from $5 to $1.
Wells Fargo analyst Stan Berenshteyn downgrades Health Catalyst (NASDAQ:HCAT) from Overweight to Equal-Weight and lowers the price target from $5 to $1.